Skip to main content
PMC home page
The BMJ logoLink to The BMJ
editorial
. 1996 Nov 16;313(7067):1219–1220. doi: 10.1136/bmj.313.7067.1219

Non-compliance with oral chemotherapy in childhood leukaemia.

J S Lilleyman, L Lennard
PMCID: PMC2352551  PMID: 8939095

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beyers N., Gie R. P., Schaaf H. S., van Zyl S., Nel E. D., Talent J. M., Donald P. R. Delay in the diagnosis, notification and initiation of treatment and compliance in children with tuberculosis. Tuber Lung Dis. 1994 Aug;75(4):260–265. doi: 10.1016/0962-8479(94)90130-9. [DOI] [PubMed] [Google Scholar]
  2. Chessells J. M., Bailey C., Richards S. M. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet. 1995 Jan 21;345(8943):143–148. doi: 10.1016/s0140-6736(95)90164-7. [DOI] [PubMed] [Google Scholar]
  3. Cummins D., Heuschkel R., Davies S. C. Penicillin prophylaxis in children with sickle cell disease in Brent. BMJ. 1991 Apr 27;302(6783):989–990. doi: 10.1136/bmj.302.6783.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davies H. A., Lennard L., Lilleyman J. S. Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance? BMJ. 1993 May 8;306(6887):1239–1240. doi: 10.1136/bmj.306.6887.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dolan G., Lilleyman J. S., Richards S. M. Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council. Arch Dis Child. 1989 Sep;64(9):1231–1234. doi: 10.1136/adc.64.9.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eden O. B., Lilleyman J. S., Richards S., Shaw M. P., Peto J. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br J Haematol. 1991 Jun;78(2):187–196. doi: 10.1111/j.1365-2141.1991.tb04415.x. [DOI] [PubMed] [Google Scholar]
  7. Gale R. P., Butturini A. Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia. Lancet. 1991 Nov 23;338(8778):1315–1318. doi: 10.1016/0140-6736(91)92604-z. [DOI] [PubMed] [Google Scholar]
  8. Gibson N. A., Ferguson A. E., Aitchison T. C., Paton J. Y. Compliance with inhaled asthma medication in preschool children. Thorax. 1995 Dec;50(12):1274–1279. doi: 10.1136/thx.50.12.1274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hicsönmez G., Ozsoylu S., Yetgin S., Zamani V., Gurgey A. Poor prognosis of childhood acute lymphoblastic leukaemia. Br Med J (Clin Res Ed) 1983 Apr 30;286(6375):1437–1437. doi: 10.1136/bmj.286.6375.1437-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lennard L., Lilleyman J. S., Van Loon J., Weinshilboum R. M. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet. 1990 Jul 28;336(8709):225–229. doi: 10.1016/0140-6736(90)91745-v. [DOI] [PubMed] [Google Scholar]
  11. Lilleyman J. S., Lennard L. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet. 1994 May 14;343(8907):1188–1190. doi: 10.1016/s0140-6736(94)92400-7. [DOI] [PubMed] [Google Scholar]
  12. MacDougall L. G., Wilson T. D., Cohn R., Shuenyane E. N., McElligott S. E. Compliance with chemotherapy in childhood leukaemia in Africa. S Afr Med J. 1989 May 20;75(10):481–484. [PubMed] [Google Scholar]
  13. Macdougall L. G., McElligott S. E., Ross E., Greeff M. C., Poole J. E. Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukemia: urinary assays as a measure of drug compliance. Ther Drug Monit. 1992 Oct;14(5):371–375. doi: 10.1097/00007691-199210000-00005. [DOI] [PubMed] [Google Scholar]
  14. Patterson J. M., Budd J., Goetz D., Warwick W. J. Family correlates of a 10-year pulmonary health trend in cystic fibrosis. Pediatrics. 1993 Feb;91(2):383–389. [PubMed] [Google Scholar]
  15. Pinkerton C. R., Welshman S. G., Glasgow J. F., Bridges J. M. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia? Lancet. 1980 Nov 1;2(8201):944–946. doi: 10.1016/s0140-6736(80)92105-4. [DOI] [PubMed] [Google Scholar]
  16. Schmidt L. E., Klover R. V., Arfken C. L., Delamater A. M., Hobson D. Compliance with dietary prescriptions in children and adolescents with insulin-dependent diabetes mellitus. J Am Diet Assoc. 1992 May;92(5):567–570. [PubMed] [Google Scholar]
  17. Smith S. D., Rosen D., Trueworthy R. C., Lowman J. T. A reliable method for evaluating drug compliance in children with cancer. Cancer. 1979 Jan;43(1):169–173. doi: 10.1002/1097-0142(197901)43:1<169::aid-cncr2820430125>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  18. Tebbi C. K., Cummings K. M., Zevon M. A., Smith L., Richards M., Mallon J. Compliance of pediatric and adolescent cancer patients. Cancer. 1986 Sep 1;58(5):1179–1184. doi: 10.1002/1097-0142(19860901)58:5<1179::aid-cncr2820580534>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  19. Tebbi C. K. Treatment compliance in childhood and adolescence. Cancer. 1993 May 15;71(10 Suppl):3441–3449. doi: 10.1002/1097-0142(19930515)71:10+<3441::aid-cncr2820711751>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  20. Viana M. B., Murao M., Ramos G., Oliveira H. M., de Carvalho R. I., de Bastos M., Colosimo E. A., Silvestrini W. S. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child. 1994 Oct;71(4):304–310. doi: 10.1136/adc.71.4.304. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES